Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Genetic predispositions, individual metabolism, and hormonal profiles can all impact how efficiently your body responds to tirzepatide
BMI doesnt reflect patterns
2026 HealthDay
Research shows that the average weight loss after 56 weeks is 8%
A 2021 study published in The New England Journal of Medicine found that individuals using semaglutide experienced an average weight reduction of up to 14.9% over 68 weeks, highlighting its effectiveness in supporting long-term weight loss
The mean differences between the treatment and placebo groups were approximately 12 centimeters across the two trials. The trials also reported: Mean trunk-fat reductions of approximately 0.81.0 kilograms Mean lean-body-mass increases of approximately 1.21.3 kilograms Little overall change in total body weight These results suggest that tesamorelin can alter the distribution of fat and lean tissue without functioning as a conventional weight-loss agent
